Pre-order Enquiry
Request Free Sample
Global and United States ALK Positive Lung Cancer Treatment Market Size, Status and Forecast 2021-2027
SKU ID : QYR-19026930 | Publishing Date : 30-Aug-2021 | No. of pages : 100
Detailed TOC of Global and United States ALK Positive Lung Cancer Treatment Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Crizotinib
1.2.3 Alectinib
1.2.4 Ceritinib
1.2.5 Brigatinib
1.2.6 Other
1.3 Market by Application
1.3.1 Global ALK Positive Lung Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global ALK Positive Lung Cancer Treatment Market Perspective (2016-2027)
2.2 ALK Positive Lung Cancer Treatment Growth Trends by Regions
2.2.1 ALK Positive Lung Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 ALK Positive Lung Cancer Treatment Historic Market Share by Regions (2016-2021)
2.2.3 ALK Positive Lung Cancer Treatment Forecasted Market Size by Regions (2022-2027)
2.3 ALK Positive Lung Cancer Treatment Industry Dynamic
2.3.1 ALK Positive Lung Cancer Treatment Market Trends
2.3.2 ALK Positive Lung Cancer Treatment Market Drivers
2.3.3 ALK Positive Lung Cancer Treatment Market Challenges
2.3.4 ALK Positive Lung Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top ALK Positive Lung Cancer Treatment Players by Revenue
3.1.1 Global Top ALK Positive Lung Cancer Treatment Players by Revenue (2016-2021)
3.1.2 Global ALK Positive Lung Cancer Treatment Revenue Market Share by Players (2016-2021)
3.2 Global ALK Positive Lung Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by ALK Positive Lung Cancer Treatment Revenue
3.4 Global ALK Positive Lung Cancer Treatment Market Concentration Ratio
3.4.1 Global ALK Positive Lung Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by ALK Positive Lung Cancer Treatment Revenue in 2020
3.5 ALK Positive Lung Cancer Treatment Key Players Head office and Area Served
3.6 Key Players ALK Positive Lung Cancer Treatment Product Solution and Service
3.7 Date of Enter into ALK Positive Lung Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 ALK Positive Lung Cancer Treatment Breakdown Data by Type
4.1 Global ALK Positive Lung Cancer Treatment Historic Market Size by Type (2016-2021)
4.2 Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Type (2022-2027)
5 ALK Positive Lung Cancer Treatment Breakdown Data by Application
5.1 Global ALK Positive Lung Cancer Treatment Historic Market Size by Application (2016-2021)
5.2 Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America ALK Positive Lung Cancer Treatment Market Size (2016-2027)
6.2 North America ALK Positive Lung Cancer Treatment Market Size by Type
6.2.1 North America ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021)
6.2.2 North America ALK Positive Lung Cancer Treatment Market Size by Type (2022-2027)
6.2.3 North America ALK Positive Lung Cancer Treatment Market Size by Type (2016-2027)
6.3 North America ALK Positive Lung Cancer Treatment Market Size by Application
6.3.1 North America ALK Positive Lung Cancer Treatment Market Size by Application (2016-2021)
6.3.2 North America ALK Positive Lung Cancer Treatment Market Size by Application (2022-2027)
6.3.3 North America ALK Positive Lung Cancer Treatment Market Size by Application (2016-2027)
6.4 North America ALK Positive Lung Cancer Treatment Market Size by Country
6.4.1 North America ALK Positive Lung Cancer Treatment Market Size by Country (2016-2021)
6.4.2 North America ALK Positive Lung Cancer Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe ALK Positive Lung Cancer Treatment Market Size (2016-2027)
7.2 Europe ALK Positive Lung Cancer Treatment Market Size by Type
7.2.1 Europe ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021)
7.2.2 Europe ALK Positive Lung Cancer Treatment Market Size by Type (2022-2027)
7.2.3 Europe ALK Positive Lung Cancer Treatment Market Size by Type (2016-2027)
7.3 Europe ALK Positive Lung Cancer Treatment Market Size by Application
7.3.1 Europe ALK Positive Lung Cancer Treatment Market Size by Application (2016-2021)
7.3.2 Europe ALK Positive Lung Cancer Treatment Market Size by Application (2022-2027)
7.3.3 Europe ALK Positive Lung Cancer Treatment Market Size by Application (2016-2027)
7.4 Europe ALK Positive Lung Cancer Treatment Market Size by Country
7.4.1 Europe ALK Positive Lung Cancer Treatment Market Size by Country (2016-2021)
7.4.2 Europe ALK Positive Lung Cancer Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size (2016-2027)
8.2 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America ALK Positive Lung Cancer Treatment Market Size (2016-2027)
9.2 Latin America ALK Positive Lung Cancer Treatment Market Size by Type
9.2.1 Latin America ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021)
9.2.2 Latin America ALK Positive Lung Cancer Treatment Market Size by Type (2022-2027)
9.2.3 Latin America ALK Positive Lung Cancer Treatment Market Size by Type (2016-2027)
9.3 Latin America ALK Positive Lung Cancer Treatment Market Size by Application
9.3.1 Latin America ALK Positive Lung Cancer Treatment Market Size by Application (2016-2021)
9.3.2 Latin America ALK Positive Lung Cancer Treatment Market Size by Application (2022-2027)
9.3.3 Latin America ALK Positive Lung Cancer Treatment Market Size by Application (2016-2027)
9.4 Latin America ALK Positive Lung Cancer Treatment Market Size by Country
9.4.1 Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2016-2021)
9.4.2 Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size (2016-2027)
10.2 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Details
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche ALK Positive Lung Cancer Treatment Introduction
11.1.4 F. Hoffmann-La Roche Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021)
11.1.5 F. Hoffmann-La Roche Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer ALK Positive Lung Cancer Treatment Introduction
11.2.4 Pfizer Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis ALK Positive Lung Cancer Treatment Introduction
11.3.4 Novartis Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 TP Therapeutics
11.4.1 TP Therapeutics Company Details
11.4.2 TP Therapeutics Business Overview
11.4.3 TP Therapeutics ALK Positive Lung Cancer Treatment Introduction
11.4.4 TP Therapeutics Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021)
11.4.5 TP Therapeutics Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb ALK Positive Lung Cancer Treatment Introduction
11.5.4 Bristol-Myers Squibb Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Company Details
11.6.2 Eli Lilly and Company Business Overview
11.6.3 Eli Lilly and Company ALK Positive Lung Cancer Treatment Introduction
11.6.4 Eli Lilly and Company Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021)
11.6.5 Eli Lilly and Company Recent Development
11.7 Takeda
11.7.1 Takeda Company Details
11.7.2 Takeda Business Overview
11.7.3 Takeda ALK Positive Lung Cancer Treatment Introduction
11.7.4 Takeda Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021)
11.7.5 Takeda Recent Development
11.8 Beacon Pharma
11.8.1 Beacon Pharma Company Details
11.8.2 Beacon Pharma Business Overview
11.8.3 Beacon Pharma ALK Positive Lung Cancer Treatment Introduction
11.8.4 Beacon Pharma Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021)
11.8.5 Beacon Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global and United States ALK Positive Lung Cancer Treatment Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Crizotinib
Table 3. Key Players of Alectinib
Table 4. Key Players of Ceritinib
Table 5. Key Players of Brigatinib
Table 6. Key Players of Other
Table 7. Global ALK Positive Lung Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global ALK Positive Lung Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global ALK Positive Lung Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global ALK Positive Lung Cancer Treatment Market Share by Regions (2016-2021)
Table 11. Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global ALK Positive Lung Cancer Treatment Market Share by Regions (2022-2027)
Table 13. ALK Positive Lung Cancer Treatment Market Trends
Table 14. ALK Positive Lung Cancer Treatment Market Drivers
Table 15. ALK Positive Lung Cancer Treatment Market Challenges
Table 16. ALK Positive Lung Cancer Treatment Market Restraints
Table 17. Global ALK Positive Lung Cancer Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global ALK Positive Lung Cancer Treatment Market Share by Players (2016-2021)
Table 19. Global Top ALK Positive Lung Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ALK Positive Lung Cancer Treatment as of 2020)
Table 20. Ranking of Global Top ALK Positive Lung Cancer Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by ALK Positive Lung Cancer Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players ALK Positive Lung Cancer Treatment Product Solution and Service
Table 24. Date of Enter into ALK Positive Lung Cancer Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global ALK Positive Lung Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America ALK Positive Lung Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America ALK Positive Lung Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America ALK Positive Lung Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America ALK Positive Lung Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America ALK Positive Lung Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe ALK Positive Lung Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe ALK Positive Lung Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe ALK Positive Lung Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe ALK Positive Lung Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe ALK Positive Lung Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America ALK Positive Lung Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America ALK Positive Lung Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America ALK Positive Lung Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. F. Hoffmann-La Roche Company Details
Table 65. F. Hoffmann-La Roche Business Overview
Table 66. F. Hoffmann-La Roche ALK Positive Lung Cancer Treatment Product
Table 67. F. Hoffmann-La Roche Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) & (US$ Million)
Table 68. F. Hoffmann-La Roche Recent Development
Table 69. Pfizer Company Details
Table 70. Pfizer Business Overview
Table 71. Pfizer ALK Positive Lung Cancer Treatment Product
Table 72. Pfizer Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) & (US$ Million)
Table 73. Pfizer Recent Development
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis ALK Positive Lung Cancer Treatment Product
Table 77. Novartis Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) & (US$ Million)
Table 78. Novartis Recent Development
Table 79. TP Therapeutics Company Details
Table 80. TP Therapeutics Business Overview
Table 81. TP Therapeutics ALK Positive Lung Cancer Treatment Product
Table 82. TP Therapeutics Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) & (US$ Million)
Table 83. TP Therapeutics Recent Development
Table 84. Bristol-Myers Squibb Company Details
Table 85. Bristol-Myers Squibb Business Overview
Table 86. Bristol-Myers Squibb ALK Positive Lung Cancer Treatment Product
Table 87. Bristol-Myers Squibb Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) & (US$ Million)
Table 88. Bristol-Myers Squibb Recent Development
Table 89. Eli Lilly and Company Company Details
Table 90. Eli Lilly and Company Business Overview
Table 91. Eli Lilly and Company ALK Positive Lung Cancer Treatment Product
Table 92. Eli Lilly and Company Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) & (US$ Million)
Table 93. Eli Lilly and Company Recent Development
Table 94. Takeda Company Details
Table 95. Takeda Business Overview
Table 96. Takeda ALK Positive Lung Cancer Treatment Product
Table 97. Takeda Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) & (US$ Million)
Table 98. Takeda Recent Development
Table 99. Beacon Pharma Company Details
Table 100. Beacon Pharma Business Overview
Table 101. Beacon Pharma Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) & (US$ Million)
Table 102. Beacon Pharma Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global ALK Positive Lung Cancer Treatment Market Share by Type: 2020 VS 2027
Figure 2. Crizotinib Features
Figure 3. Alectinib Features
Figure 4. Ceritinib Features
Figure 5. Brigatinib Features
Figure 6. Other Features
Figure 7. Global ALK Positive Lung Cancer Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Clinics Case Studies
Figure 10. Other Case Studies
Figure 11. ALK Positive Lung Cancer Treatment Report Years Considered
Figure 12. Global ALK Positive Lung Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global ALK Positive Lung Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global ALK Positive Lung Cancer Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global ALK Positive Lung Cancer Treatment Market Share by Regions (2022-2027)
Figure 16. Global ALK Positive Lung Cancer Treatment Market Share by Players in 2020
Figure 17. Global Top ALK Positive Lung Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ALK Positive Lung Cancer Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by ALK Positive Lung Cancer Treatment Revenue in 2020
Figure 19. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America ALK Positive Lung Cancer Treatment Market Share by Type (2016-2027)
Figure 23. North America ALK Positive Lung Cancer Treatment Market Share by Application (2016-2027)
Figure 24. North America ALK Positive Lung Cancer Treatment Market Share by Country (2016-2027)
Figure 25. United States ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe ALK Positive Lung Cancer Treatment Market Share by Type (2016-2027)
Figure 29. Europe ALK Positive Lung Cancer Treatment Market Share by Application (2016-2027)
Figure 30. Europe ALK Positive Lung Cancer Treatment Market Share by Country (2016-2027)
Figure 31. Germany ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific ALK Positive Lung Cancer Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific ALK Positive Lung Cancer Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific ALK Positive Lung Cancer Treatment Market Share by Region (2016-2027)
Figure 41. China ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America ALK Positive Lung Cancer Treatment Market Share by Type (2016-2027)
Figure 49. Latin America ALK Positive Lung Cancer Treatment Market Share by Application (2016-2027)
Figure 50. Latin America ALK Positive Lung Cancer Treatment Market Share by Country (2016-2027)
Figure 51. Mexico ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa ALK Positive Lung Cancer Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa ALK Positive Lung Cancer Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa ALK Positive Lung Cancer Treatment Market Share by Country (2016-2027)
Figure 57. Turkey ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. F. Hoffmann-La Roche Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2016-2021)
Figure 63. TP Therapeutics Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2016-2021)
Figure 64. Bristol-Myers Squibb Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2016-2021)
Figure 65. Eli Lilly and Company Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2016-2021)
Figure 66. Takeda Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2016-2021)
Figure 67. Beacon Pharma Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Keyplayers in Global and United States ALK Positive Lung Cancer Treatment Market Size, Status and Forecast 2021-2027
F. Hoffmann-La RochePfizer
Novartis
TP Therapeutics
Bristol-Myers Squibb
Eli Lilly and Company
Takeda
Beacon Pharma
Request Sample
Request Discount
